Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 199.20

+0.1%

Nov 21 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: squetch who wrote (10481)	10/31/1997 2:26:00 AM
From: Andrew H	Read Replies (1) of 32384

squelchers, want to congratulate you on ferreting out the SRGN drug as the one LGND will choose (if it turns out that way). Still, seems like Targretin is already highly effective for CTCL and the market is pretty small, so I don't see a lot of profit for the drug. Maybe they want to buy out the competition? Of course there is also the lung cancer indication but that is in the future. Sounds like they will not get the psoriasis indication unless they buy the company. Do you have any thoughts about this? I guess we'll find out more in a couple of weeks. Clearly LGND knows a lot more about the drug than we do.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next